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Abstract
During apoptosis several mitochondrial proteins are released. Some of them participate in caspase-
independent nuclear DNA degradation, especially apoptosis-inducing factor (AIF) and
endonuclease G (endoG). Another interesting protein, which was expected to act similarly as AIF
due to the high sequence homology with AIF is AIF-homologous mitochondrion-associated inducer
of death (AMID). We studied the structure, cellular localization, and interactions of several
proteins in silico and also in cells using fluorescent microscopy. We found the AMID protein to be
cytoplasmic, most probably incorporated into the cytoplasmic side of the lipid membranes.
Bioinformatic predictions were conducted to analyze the interactions of the studied proteins with
each other and with other possible partners. We conducted molecular modeling of proteins with
unknown 3D structures. These models were then refined by MolProbity server and employed in
molecular docking simulations of interactions. Our results show data acquired using a combination
of modern in silico methods and image analysis to understand the localization, interactions and
functions of proteins AMID, AIF, endonuclease G, and other apoptosis-related proteins.
Background
During some forms of apoptosis the mitochondrial outer
membrane becomes depolarized and partially permeable
to proteins. This results in a massive nonspecific release of
hydrophilic proteins from the intermembrane space into
the cytoplasm [1]. Among these proteins are apoptosis-
inducing factor (AIF) and endonuclease G (endoG). The
release of these proteins results in activation of the apop-
totic caspases, degradation of nuclear DNA, and cell death
[2,3]. However, both AIF and endoG have been found to
directly participate in DNA degradation in a caspase-inde-
pendent way [4]. The protein AIF-homologous mitochon-
drion-associated inducer of death (AMID), which is
probably not located in the mitochondrion, shares
sequence homology with AIF and exerts similar apoptotic
effects on nuclear chromatin [5]. Interestingly, endoG, AIF
and AMID have all been found to influence chromatin
changes during apoptosis [6].
EndoG is a mitochondrial nuclease with a molecular
weight of 30 kDa. Its N-terminus contains a mitochon-
drial localization sequence (MLS), which is cleaved upon
successful transport of the endoG precursor polypeptide
across the outer mitochondrial membrane. EndoG
migrates from mitochondria into the nucleus after apop-
togenic stimuli [7,8]. Addition of endoG to isolated cell
nuclei resulted in cleavage of the chromatin into large
fragments (~50 kbp) and subsequently into inter- and
intra-nucleosomal-size fragments with periodically
repeated single-stranded breaks. The first phase of endoG
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activity equates with the large-scale degradation of DNA
during apoptosis, but the second phase would not seem to
be able to generate the characteristic "laddered" fragmen-
tation of chromatin observed in apoptotic nuclei. This
may suggest that endoG normally interacts with other
nucleases. Indeed, cooperation between endoG, DNase I
and exonuclease III has been shown to occur only on iso-
lated dsDNA [6]. Another proposed interaction partner
for endoG was found by protein analytic in vitro methods
to be flap endonuclease 1 [9], but it was not yet shown in
living or fixed cells as many other possible interactions
mentioned here.
AIF (also known as AIFM1 or PDCD8) is an evolutionary
conserved flavoprotein. It shares a high degree of
sequence homology with bacterial, plant, and fungal oxi-
doreductases. The human AIF is expressed as a precursor
polypeptide of molecular weight ~67 kDa. This precursor
contains an N-terminal MLS, which is cleaved, and the
active AIF (~57 kDa) is created in the mitochondrial inter-
membrane space [10]. AIF is probably bound by its N-ter-
minus to the surface of the inner mitochondrial
membrane [11,12]. The function of AIF in the mitochon-
drion under non-apoptotic conditions is not clear, but
there is evidence that AIF may serve to sequester free radi-
cals and that it can play important role in oxidative phos-
phorylation [13,14]. However, human AIF is also able to
induce apoptosis [10]. None of these effects could be
inhibited by the pan-caspase inhibitor z-VAD-fmk, thus
they are caspase-independent [15]. Translocation of AIF
into the nucleus occurs during apoptosis [15,16]. The C.
elegans homologue of AIF, known as WAH-1, was shown
to induce apoptosis and to migrate from mitochondria to
the nucleus, where it interacts with a nuclease, CPS-6 (a
homologue of the mammalian endoG), and together they
mediate chromatin DNA degradation [17]. There is no
clear evidence as to how mammalian AIF is involved in
the process of chromatin degradation, but AIF can physi-
cally interact with DNA and RNA [18]. Interaction of
human AIF and endoG, in analogy to what happens in C.
elegans, has not yet been shown, although protein analysis
in vitro results suggest its possibility [9]. However, other
important proteins have been proposed to interact with
AIF, namely cyclophilin A [19] and heat shock 70 kDa
protein 1A (HSP70-1) [20]. Cyclophilin A is involved in
transport of AIF into the nucleus and may be also involved
in chromatin degradation [19,21]. HSP70-1 binds AIF in
the cytoplasm and blocks its transport into the nucleus
[22]. Another protein, DNA topoisomerase II α, was
found to be involved in chromatin degradation during
caspase-independent apoptosis and is therefore one of
our candidate proteins that may interact with AIF in
nucleus [23].
AMID (also known as AIFM2 or PRG3) is a flavoprotein
with amino acid sequence similarity to NADH oxidore-
ductases in all species, as well as to AIF (22% identity). In
contrast to AIF, AMID does not contain a recognizable
MLS [5]. AMID was found to associate with the outer
mitochondrial membrane [5] or to be freely distributed in
the cytoplasm [24]. Apoptosis induced by AMID is regu-
lated by p53, is caspase-independent, and is not affected
by overexpression of the Bcl-2 protein [5]. Artificially
induced overexpression of AMID caused chromatin con-
densation at the nuclear periphery and formation of
apoptotic bodies [24]. However, this was not confirmed
by another study [5]. Overexpression of AMID also caused
a loss of structurally differentiated mitochondria [5].
However, recent results did not show that AMID acts sim-
ilarly to AIF and it's localization was also questioned
[25,26].
Therefore, in this work we use modern in silico methods
for sequence analysis, predicting the subcellular localiza-
tion of proteins, prediction of interactions, molecular
modeling and docking and we combined these methods
with fluorescence microscopic imaging of endoG, AIF,
AMID, and other apoptotic proteins in living or fixed cells
to analyze their localization and interactions.
Materials and methods
Cell culture
Human bone osteosarcoma U-2 OS cells were grown in
minimal essential medium containing Earle's balanced
salts, L-glutamine, non-essential amino acids, 1.5 g/l
NaHCO3, 10% fetal bovine serum, 100 U/ml of penicillin
and 100 μg/ml of streptomycin at 37°C in a 5% CO2
atmosphere.
Plasmid DNA preparation and transfection
The plasmid constructs carrying the genes for endoG-
EYFP, AIF-tHcRed, and AMID-tHcRed fluorescent fusion
proteins were described previously [25]. Cells were trans-
fected using FuGENE 6 (Roche). In cases of transient
transfection, the transfected cells were used for experi-
ments 24 hours after transfection. Stably transfected cell
cultures were selected using 600 μg/ml of geneticine
(G418) for 14 days.
Prediction of protein's cellular localization
Prediction analysis was conducted using amino acid
sequences of the endonuclease G protein precursor (Gen-
Bank Accession Number NP_004426), isoform 1 of pro-
tein AIF (NP_004199), AMID (NP_116186), HSP70-1
protein (NP_005336), cyclophilin A (NP_066953), DNA
topoisomerase II α (NP_001058). Four internet server
tools specialized in predicting cellular localization of pro-
teins from their amino acid sequences were employed:Journal of Biomedical Science 2009, 16:59 http://www.jbiomedsci.com/content/16/1/59
Page 3 of 14
(page number not for citation purposes)
PSORT II [27,28], WoLF PSORT [29], MultiLoc [30], and
CELLO v.2.5 [31].
Fluorescence microscopy
Image data acquisition was done using the high-resolu-
tion cytometer (HRCM) developed in our laboratory
[25,32,33]. The HRCM system was controlled by FISH 2.0
software or by new Acquiarium 1.0 software, both devel-
oped in our laboratory [32-34]. Immunostaining was
done using fluorescently labeled primary antibodies
labeled using kits with Alexa Fluor dyes 488 and 568 (Inv-
itrogen – Molecular Probes). Rabbit polyclonal anti-
human AIF and endoG (Abcam) and mouse monoclonal
anti-human cyclophilin A and DNA topoisomerase II α
(Tebu-bio) primary antibodies were used. Cells were usu-
ally grown in Lab-Tek chambers (Nunc) or grown on cov-
erglass in petri dish. Samples were fixed using 4%
paraformaldehyde. Obtained image data were decon-
volved using the plugins Diffraction PSF 3D and Iterative
Deconvolve 3D for ImageJ software [35].
Molecular modeling
Prediction servers can use the known 3D protein structure
with amino acid sequence homologous to the protein of
interest and predict its 3D structure based on this homol-
ogy. We used servers Phyre [36,37] and M4T [38] for such
3D structure modeling after intensive testing of various
servers. Visualization of 3D protein structures was done
using software UCSF Chimera [39]. The server tool Mol-
Probity [40] was used for protein model validation and
refinement.
Prediction of interactions
Interaction prediction analysis was conducted using two
web server tools for predicting interaction sites in proteins
from their 3D structure. Cons-PPISP [41] for prediction of
protein-protein interaction residues and DISPLAR [42] for
prediction of DNA binding residues.
Molecular docking
We accomplished the molecular docking using one of the
most modern server docking tools PatchDock with refine-
ment tool FireDock [43,44]. For molecular docking were
used optimized PDB files of 3D structures from RCSB Pro-
tein Data Bank (for AIF it was PDB ID 1m6i, for B-DNA it
was PDB ID 1bna, and for cyclophilin A it was PDB ID
1W8M) or our prepared models. The 10 best solutions
were saved and submitted to following analysis and
refinement by FireDock tool. Again the best 10 solutions
and calculations were also saved and then studied.
Results
Sequence analysis and prediction of subcellular locations 
of proteins
We analyzed the amino acid sequences of AIF and AMID
by BLAST server using tool Search Conserved Domains
and using tool Blast 2 sequences [45] to study the align-
ment and the conserved domains of these two proteins
(Fig. 1A). Results clearly show that sequence homology of
these two proteins is restricted to Ndh (NADH dehydroge-
nase, FAD-containing subunit) conserved domain. Predic-
tions of the subcellular locations of endoG, AIF, AMID,
cyclophilin A, HSP70-1, and DNA topoisomerase II α
were made using four prediction servers: PSORT II, WoLF
PSORT, MultiLoc, and CELLO. Although most of the ana-
lyzed proteins have known cellular location, we neverthe-
less employed these server tools to validate the accuracy of
a final prediction summary based on the combined results
of these tools (Table 1). These results clearly indicate that
the predicted cellular location of endoG and AIF is in the
mitochondrion, cyclophilin A and HSP70-1 in the cyto-
plasm, and DNA topoisomerase II α in the nucleus. For
AMID, the most probable subcellular location was pre-
dicted to be the cytoplasm (Table 1). The individual
PSORT II algorithms revealed the MLS in endoG sequence
to be the N-terminal 48-amino-acid cleavable signal pep-
tide [46,47] and the nuclear localization signal (NLS) at
position 24 [48] inside the predicted MLS (Fig. 1B). In the
sequence of AIF isoform 1 we predicted the MLS to be the
N-terminal 61-amino-acid cleavable signal peptide
[46,47], the NLS at positions 106 – 112 [48], and one
transmembrane segment between positions 68 – 84 (Fig.
1B) [27]. The PSORT II algorithms discovered an N-myr-
istoylation-allowing motif [49] which would potentially
permit incorporation of AMID into various cellular mem-
branes [50] and one transmembrane segment between
positions 11 – 33 by TMHMM 2.0 server (Fig. 1B) [51]. N-
myristoylation-allowing motif was also detected by two
other bioinformatic tools – the Myristoylator [52] and the
NMT Predictor [53], which defined the motif to be the
amino acid sequence GSQVSVESGALHVVIVG starting at
position 2. In the sequence of HSP70-1 were detected NLS
at positions 246 – 273 and 594 – 597. PSORT II and
TMHMM 2.0 found nothing of interest for cyclophilin A.
In the sequence of DNA topoisomerase II α were pre-
dicted several NLS between amino acids 632 to 1468.
Experimental cellular locations of proteins
Experimental determination of the cellular locations of
studied proteins was conducted either by transfecting liv-
ing cells with mammalian expression vectors encoding
the fusion proteins or by immunostaining of fixed cells by
fluorescently labeled primary antibody. Figure 2A shows a
typical signal distributions of endoG-EYFP and AMID-
tHcRed fluorescence in transfected human living U-2 OS
cells. Apparently, AMID and endoG do not colocalize sig-Journal of Biomedical Science 2009, 16:59 http://www.jbiomedsci.com/content/16/1/59
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Sequence analysis and prediction of cellular locations of proteins Figure 1
Sequence analysis and prediction of cellular locations of proteins. (A) Homology of sequences of AIF and AMID with 
detected conserved domains. (B) Sequences of AIF, AMID, and endoG with detected conserved domains and predicted sites. 
Pyr_Redox – NADH binding domain within a larger FAD binding domain of pyridine nucleotide-disulphide oxidoreductase; 
Ndh – FAD-containing subunit of NADH dehydrogenase; Nuc – DNA/RNA non-specific endonuclease; MLS – mitochondrial 
localization sequence; NLS – nuclear localization signal; M – N-myristoylation-allowing motif; TM – transmembrane region.Journal of Biomedical Science 2009, 16:59 http://www.jbiomedsci.com/content/16/1/59
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Table 1: Prediction of cellular localization.
Endonuclease G PSORT II (%) WoLF PSORT (%) MultiLoc (%) Cello (reliability)
mitochondrion 30.4 25.9 98.0 3.08
cytoplasm 34.8 6.9 0.0 0.33
endoplasmic reticulum 8.7 - - 0.03
Golgi apparatus - 10.3 - 0.01
lysosome/vacuole 8.7 13.8 - 0.03
peroxisome - 15.5 1.0 0.20
plasma membrane 8.7 - - 0.40
nucleus 8.7 3.4 - 0.43
cystoskeleton - - - 0.01
AIF
mitochondrion 39.1 69.0 97.0 2.53
cytoplasm 26.1 8.6 1.0 0.40
endoplasmic reticulum 17.4 - - 0.01
Golgi apparatus 13.0 - - 0.02
lysosome/vacuole 4.3 - - 0.01
peroxisome - 6.9 2.0 0.14
plasma membrane - 6.9 - 0.04
nucleus - 5.2 - 0.04
cystoskeleton - - - 0.00
AMID
mitochondrion 8.7 3.1 7.0 1.58
cytoplasm 60.9 12.5 59.0 0.58
endoplasmic reticulum - - - 0.05
Golgi apparatus 13.0 3.1 - 0.04
lysosome/vacuole 4.3 - - 0.03
peroxisome - 12.5 31.0 0.25
plasma membrane - 18.8 - 0.37
nucleus 4.3 12.5 - 0.17
cystoskeleton - - - 0.01
Cyclophilin A
mitochondrion 4.3 6.3 1.0 0.33
cytoplasm 60.9 79.7 93.0 4.18
endoplasmic reticulum - - - 0.09
Golgi apparatus - 3.2 - 0.01
lysosome/vacuole 4.3 - - 0.02
peroxisome - - 5.0 0.03
plasma membrane - - - 0.03
nucleus 17.4 2.5 - 0.12
cytoskeleton 4.3 - - 0.00
HSP70-1
mitochondrion - 3.2 2.0 0.47
cytoplasm 73.9 59.4 36.0 3.08
endoplasmic reticulum 4.3 - - 0.22
Golgi apparatus - - - 0.04
lysosome/vacuole - - - 0.01
peroxisome - - 61.0  0.10
plasma membrane - 3.2 - 0.02
nucleus 21.7 21.9 - 0.20
cytoskeleton - 9.4 - 0.02Journal of Biomedical Science 2009, 16:59 http://www.jbiomedsci.com/content/16/1/59
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nificantly. EndoG is present in mitochondria and AMID is
present throughout the cytoplasm apparently on various
structures [25]. Figures 2B and 2C show signal distribu-
tion of AMID-tHcRed fluorescence in living U-2 OS cell
before and 6 hours after induction of apoptosis by 200
nM staurosporine. Figure 2C clearly shows that AMID
does not translocate to nucleus. Figure 2D shows the flu-
orescence signal of endoG-EYFP in one living cell over-
expressing endoG which distributed inside nucleus,
although the cell is viable and non-apoptotic. Transloca-
tion of endoG into the cell nucleus during staurosporine-
induced apoptosis is shown in Figures 2E and 2F. We co-
immunostained AIF and cyclophlilin A in fixed U-2 OS
cells (Fig. 2G). AIF is located to mitochondria and cyclo-
philin A to the cytoplasm and also to the cell nucleus.
Apoptosis induced in these cells resulted into nuclear
translocation of AIF (Fig. 2H) and cyclophilin A remained
in nucleus and cytoplasm (Fig. 2I). Immunostaining by
fluorescent antibodies against DNA topoisomerase II α
revealed the expected nuclear localization of the protein
(Fig. 2J). Interestingly, after apoptosis induction by 200
nM staurosporine, DNA topoisomerase II α in nucleus
displayed distribution similar to chromatin condensation
attributed to effect of AIF during apoptosis (Fig. 2K and
2L). HSP70-1 immunostaining showed not only cytoplas-
mic localization of the protein (Fig. 2N) but also strong
nucleoli localization of HSP70-1 after heat shock at 42°C
for 2 hours (Fig. 2M). Interestingly, after apoptosis induc-
tion by 200 nM staurosporine, HSP70-1 relocated to the
cell nucleus (Fig. 2O).
Molecular modeling
We prepared 3D models of protein structure of several
proteins using various modeling servers and we selected
only the best models ranked by MolProbity [40] server.
MolProbity server also refined the structure of models and
these refined models were used in our following predic-
tions and molecular dockings. Best endoG model (pre-
pared from 1G8T structure) was prepared by Phyre server
[36] (MolProbity score 2.96) and consists of amino acids
65–296 from 297 amino acids (Fig. 3). We also prepared
model of HSP70-1 protein (MolProbity score 2.68) by
M4T server [38] for amino acids range of 1–554 from 641
amino acids (Fig. 3). Another two models were prepared
again by Phyre server for proteins WAH-1 (amino acids
238–700 of 700; MolProbity score 3.02) and CPS-6
(amino acids 57–305 of 308; MolProbity score 3.06) (Fig.
3).
Prediction of interactions
Using servers cons-PPISP [41] and DISPLAR [42] we pre-
dicted the possible binding sites for proteins (cons-PPISP)
and DNA (DISPLAR) in the sequences of AIF, endonucle-
ase G, and cyclophilin A. These predictions are based on
3D structures of these proteins. Using cons-PPISP server
we found several residues that can form binding sites in
the AIF amino acid sequence. The binding residues are in
the interval of amino acids 264–498 and at the C-termi-
nus (amino acids 598–608). For endoG we predicted two
possible binding regions for amino acids 75–96 and 265–
282 (C-terminus). We found a high concentration of pos-
sible binding residues at amino acids 88–97 and 116–138
for cyclophilin A. Using DISPLAR server, we were able to
detect possible locations for DNA binding residues in the
sequence of AIF especially at interval of amino acids 237–
254. EndoG sequence showed three intervals containing
predicted residues at positions 100–115, 139–153, and
177–188. For cyclophilin A, we detected cluster of pre-
dicted residues for DNA binding in the interval of amino
acids 54–72.
Molecular docking
Docking represents the mathematical calculation of the
most probable spatial orientation of two interacting mol-
ecules, usually a protein and a small ligand, two interact-
ing proteins, or DNA and protein. Various parameters are
calculated to evaluate possibility of such interaction. For
molecular docking we used new server PatchDock [43]
with refinement tool FireDock [44]. We modeled the pro-
posed interaction of AIF with B-DNA [18] using these
DNA topoisomerase II α
mitochondrion - 1.6 - 0.10
cytoplasm 17.4 31.3 2.0 0.30
endoplasmic reticulum - - - 0.03
Golgi apparatus - - - 0.01
lysosome/vacuole - - - 0.00
peroxisome - - 1.0 0.01
plasma membrane - - - 0.11
nucleus 78.3 67.5 96.0 4.33
cytoskeleton - - - 0.02
Sequence analysis of localization of endonuclease G, AIF, AMID, cyclophilin A, HSP70-1, and DNA topoisomerase II α. Bold underlined numbers 
represent final combined prediction result for corresponding protein. Italic underlined numbers mark the highest probabilities, which are different 
from the final combined prediction result.
Table 1: Prediction of cellular localization. (Continued)Journal of Biomedical Science 2009, 16:59 http://www.jbiomedsci.com/content/16/1/59
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Figure 2 (see legend on next page)Journal of Biomedical Science 2009, 16:59 http://www.jbiomedsci.com/content/16/1/59
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tools and best docking model is shown (Fig. 4A). Global
energy function of this complex was calculated by Fire-
Dock server to be -16.84 of relative units (this value is con-
sidered to be related to free binding energy and higher
negative value means higher free binding energy and thus
higher interaction probability). Another experimentally
shown interaction pair we studied was AIF and cyclophi-
lin A (Fig. 4B) [19]. Global energy value of this complex
was -8.41. Next we modeled the possible interaction of
AIF and endoG (Fig. 4C) resulting in global energy value -
26.27 for this complex. Lastly, we modeled experimen-
tally proved interaction of analogues of AIF and endoG,
WAH-1 and CPS-6 (Fig. 4D) [17]. Resulting global energy
was -13.11. Figure 5 shows parts of modeled docking
complexes described above with focus on visualization of
binding sites. In green color are shown residues predicted
by cons-PPISP or DISPLAR servers mentioned above that
can form binding sites for protein-protein and protein-
DNA interactions.
Discussion
We clearly show that sequence homology of AIF and
AMID is restricted to Ndh conserved domain, that corre-
sponds to oxidoreductase function and not to apoptotic
function of AIF, which was shown to reside in large C-ter-
minal part of AIF sequence, which is totally missing in
AMID sequence (Fig. 1A) [54]. AMID sequence contains,
aside from Ndh conserved domain and N-terminal part,
only very small C-terminal part consisting of only several
residues and thus it is highly improbable that AMID will
act similarly as AIF during apoptosis. We correctly pre-
dicted that endoG and AIF would localize to the mito-
chondria, HSP70-1 and cyclophilin A to the cytoplasm,
and DNA topoisomerase II α to the nucleus (Table 1). The
cytoplasm was found as the most probable cellular loca-
tion for AMID (Table 1). This result is in agreement with
previous observations [25], although some of them
described the distribution of AMID in the cytoplasm dif-
ferently [5,24]. No recognizable localization signal was
found in the AMID amino acid sequence. However, the
MLS was detected as the first 48 amino acids of the endoG
sequence and as the first 61 amino acids of the AIF
sequence [55]. This finding corroborates the many pub-
lished observations that these proteins are translocated
into the nucleus during apoptosis [7,15,56]. Interestingly,
the predicted NLS of endoG is located within the MLS, so
that once endoG enters the mitochondrion the NLS will
be cleaved together with the MLS. NLS was found in
sequences of DNA topoisomerase II α, which was
expected, due to function of this protein. Interestingly,
NLS was also found in the sequence of HSP70-1 suggest-
ing its possible role in nucleus. HSP70-1 was found in
nucleoli after the heat shock [57]. The algorithms and
TMHMM 2.0 server also predicted that the sequence of
endoG, cyclophilin A, HSP70-1 and DNA topoisomerase
II α do not contain any transmembrane regions. However,
PSORTII algorithms and TMHMM 2.0 revealed that AIF
and AMID sequences contain one predicted transmem-
brane region thus suggesting that AIF and AMID could be
membrane proteins [11,58]. When apoptosis is induced
the AIF protein is spliced probably by calpain I and looses
its N-terminal part that contains the predicted transmem-
brane region and AIF is thus released into the intermem-
brane space and out of mitochondria [59]. Sequence of
cyclophilin A showed no recognizable regions and is
therefore interesting, that this protein is often found in
nucleus, which may support the possibility that cyclophi-
lin A interacts with AIF which contains NLS and together
they translocates to nucleus [19]. The lipid anchoring is
also possible for AMID, mediated by its identified puta-
tive N-myristoylation site. This site allows AMID to incor-
porate into various cellular membranes. Our findings thus
predict that AMID is by N-terminal part incorporated into
cellular membranes from cytoplasmic side.
Fluorescence imaging of living cells and microscopy of
immunostained fixed cells (Fig. 2) confirmed the pre-
dicted localization of studied proteins (Table 1). AIF and
Living cells expressing fusion proteins and immunostained fixed cells Figure 2 (see previous page)
Living cells expressing fusion proteins and immunostained fixed cells. Representative fluorescent images of living U-2 
OS cells expressing endoG-EYFP (green) and AMID-tHcRed (red) (A), AMID-tHcRed (B), and AMID-tHcRed 6 hours after 
induction of apoptosis by addition of 200 nM staurosporine (C). Representative fluorescent images of stably transfected living 
cell U-2 OS over-expressing endoG-EYFP (D), living cell U-2 OS expressing endoG-EYFP before (E) and 6 hours after (F) apop-
totic induction by 200 nM staurosporine. Fixed U-OS cells immunostained with fluorescently labeled primary antibodies against 
human AIF (red) and cyclophilin A (green) (G), U-2 OS cell 6 hours after induction of apoptosis by 200 nM staurosporine 
immunostained against human AIF (H) and cyclophilin A (I). Representative fluorescent images of fixed U-2 OS cells immunos-
tained with fluorescently labeled primary antibodies against human DNA topoisomerase II α at non-apoptotic condition (J), 3 
(K) and 6 (L) hours after induction of apoptosis by 200 nM staurosporine. Representative fluorescent images of fixed U-2 OS 
cells immunostained with fluorescently labeled primary antibodies against human HSP70-1 after heat shock for 2 hours at 42°C 
(M), fixed U-2OS cells immunostained against human HSP70-1 before (N) and 6 hours after (O) apoptotic induction by 200 nM 
staurosporine. Bottom parts of figures J, K, L, N, O contain representative sections of XZ projections of acquired 3D images. 
Scale bars = 10 μm.Journal of Biomedical Science 2009, 16:59 http://www.jbiomedsci.com/content/16/1/59
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3D structure models of proteins Figure 3
3D structure models of proteins. Models for proteins WAH-1 (modeled amino acids 238–700 of 700), CPS-6 (modeled 
amino acids 57–305 of 308), and endoG (modeled amino acids 65–296 of 297) were calculated using Phyre server. Model of 
HSP70-1 (modeled amino acids 1–554 of 641) was calculated by server M4T. Structures were visualized using UCSF Chimera 
software.Journal of Biomedical Science 2009, 16:59 http://www.jbiomedsci.com/content/16/1/59
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Molecular docking Figure 4
Molecular docking. Resulting complexes obtained by molecular docking conducted by PatchDock and refined by FireDock. 
Figures represent probable binding configuration of AIF with ideal B-DNA (A), AIF with cyclophilin A (B), AIF with endoG (C), 
and WAH-1 with CPS-6 (D). Structures were visualized using UCSF Chimera software.Journal of Biomedical Science 2009, 16:59 http://www.jbiomedsci.com/content/16/1/59
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Predicted binding sites visualization in molecular docking results Figure 5
Predicted binding sites visualization in molecular docking results. Visualization of predicted binding residues sug-
gested by DISPLAR server for protein-DNA binding and by cons-PPISP server for protein-protein binding. Figures A, C, and E 
show predicted protein-DNA binding residues in structure of AIF (A), endoG (C), and cyclophilin A (E). Figures B, D, and F 
show predicted protein-protein binding sites in structure of AIF (B), endoG (D), and cyclophilin A (F). Structures were visual-
ized using UCSF Chimera software.Journal of Biomedical Science 2009, 16:59 http://www.jbiomedsci.com/content/16/1/59
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endoG localized to mitochondria (Fig. 2A, E, G) and DNA
topoisomerase II α to nucleus (Fig. 2J). DNA topoisomer-
ase II α was also found to relocate during apoptosis simi-
larly to chromatin condensation organized by AIF (Fig. 2K
and 2L). This can point to possible interaction of DNA
topoisomerase II α with AIF or it simply binds to con-
densed chromatin during apoptosis. Apart from cytoplas-
mic distribution, cyclophilin A surprisingly showed
strong nuclear staining (Fig. 2G) maintained even during
apoptosis (Fig. 2I), although its sequence does not con-
tain any recognizable signals or motifs. Cyclophilin A can
probably bind other protein that can translocate to
nucleus even at non-apoptotic conditions. Immunostain-
ing of HSP70-1 after strong heat shock showed significant
nuclear localization of HSP70-1 into nucleoli (Fig. 2M) as
was already observed [57]. Localization of HSP70-1 in
non-apoptotic conditions was found to be cytoplasmic as
predicted (Fig. 2N), but suprisingly during apoptosis
HSP70-1 translocated into the cell nucleus (Fig. 2O),
which even more strongly supports the possible role of
this protein in apoptosis and it also corresponds to our
prediction results. Cells of normal morphology expressing
high levels of endoG-EYFP were identified in stably trans-
fected clones. The signal comprised not only the mito-
chondrial fluorescence but also a strong confluent
fluorescence in the cytoplasm and even in the nuclear
chromatin (Fig. 2D). Such cells showed no morphological
apoptotic changes. Thus the presence of endoG in the
cytoplasm and nucleus was not sufficient to induce apop-
totic chromatin degradation in the cells. This confirms our
bioinformatic predictions about endoG, that the NLS of
endoG can transport endoG-EYFP into the nucleus when
the protein is highly overexpressed in the cytoplasm.
These findings present the experimental evidence that the
mere presence of endoG in the nucleus is not sufficient to
initiate DNA cleavage and, although it is a nuclease,
endoG apparently needs to be activated to degrade DNA
in living cells [6,60]. The fluorescence signal of AMID-
tHcRed was distributed throughout the cytoplasm,
although not diffuse as was suggested [24]. AMID was
found to localize to unidentified regions throughout the
entire cell (Fig. 2A and 2B). AMID-tHcRed localized close
to the nuclear membrane, possibly with the Golgi appara-
tus and/or the endoplasmic reticulum; it was also associ-
ated with small vesicles in the cytoplasm and possibly
with the plasma membrane and it does not translocate to
the nucleus during apoptosis (Fig. 2C) [25,26]. Cells over-
expressing AMID-tHcRed were viable with normal mor-
phology, and overexpression of AMID was not sufficient
to induce apoptosis; thus, our results challenge a previous
report that overexpression of AMID could induce apop-
totic degradation of chromatin and the loss of structurally
differentiated mitochondria [5].
We prepared 3D structural models for proteins without
known 3D structure (Fig. 3). Both, these refined models
and known protein structures, were used for in silico pre-
diction of locations of binding residues for DNA and pro-
teins. We studied especially molecules that were shown to
interact with AIF or are possible candidates for such inter-
action. Especially we studied the interaction of AIF with B-
DNA (Fig. 4A) and cyclophilin A (Fig. 4B) using molecu-
lar modeling. We also studied the hypothetical possible
interaction of AIF with endoG (Fig. 4C), based on know
interaction of their analogues WAH-1 and CPS-6 from
Caenorhabditis elegans (Fig. 4D) [17]. The resulting values
produced by FireDock server tool are suggesting that inter-
action of AIF with endoG is very probable due to the high
negative value of global energy function, comparable to
other known interactions. We visualized the predicted
binding residues from servers cons-PPISP and DISPLAR in
our molecular docking complexes (Fig. 5). This novel vis-
ualization clearly shows, that molecular docking results
and binding residues predictions corresponds very well,
thus supporting results of each other and verifying the
binding residues locations and molecular binding spatial
configuration of the studied proteins.
Our results show great possibilities of in silico methods
and image analysis to understand the localization, inter-
actions and functions of proteins. Our results present new
data about the structure, localization, functions and inter-
actions of proteins AMID, AIF, endonuclease G, and other
apoptosis-related proteins.
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